If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Debridat Side Effects Reported to FDA

Debridat Side Effect Report#9245408 Surgery

This is a report of a 88-year-old male patient (weight: NA) from PE, suffering from the following health symptoms/conditions: NA, who was treated with Debridat (dosage: NA, start time: NS), combined with:

Norvastor

and developed a serious reaction and side effect(s): Surgery after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Debridat treatment in male patients, resulting in Surgery side effect.

Debridat Side Effect Report#9003606 Rash Morbilliform

This report suggests a potential DebridatRash Morbilliform side effect(s) that can have serious consequences. A 58-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Debridat (dosage: 1 Df, 4x/day) starting

Jun 30, 2012. After starting Debridat the patient began experiencing various side effects, including: Rash MorbilliformAdditional drugs used concurrently:

Furosemide (Unk)

Rocephine (1 G, 1x/day)

Flagyl (1 Df, 3x/day)

Zophren (1 Df, As Needed)

Calciparin (1 Df, 2x/day)

Acupan (Unk)

Aranesp

Paracetamol (1 G, 4x/day)

The patient was hospitalized. Although Debridat demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Rash Morbilliform, may still occur.

This Prothrombin Time Shortened problem was reported by a health professional from France. A 48-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On

Jan 22, 2012 this consumer started treatment with Debridat (dosage: 100 Mg, 3x/day). The following drugs were being taken at the same time:

Levothyroxine Sodium

Ibuprofen (400 Mg, 3x/day)

When using Debridat, the patient experienced the following unwanted symptoms/side effects: Prothrombin Time Shortened, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Transaminases Increased, Blood Bilirubin IncreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Prothrombin Time Shortened, may become evident only after a product is in use by the general population.

This Blood Alkaline Phosphatase Increased side effect was reported by a health professional from France. A 48-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Debridat (drug dosage: 100 Mg, 3x/day), which was initiated on

This is a report of a male patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Debridat (dosage: 100mg Three Times Per Day, start time:

Feb 06, 2012), combined with:

Spasfon (30mg Twice Per Day)

Doxorubicin Hcl (44mg Per Day)

Isentress (400mg Twice Per Day)

Vinblastine Sulfate (10.5mg Per Day)

Acetaminophen And Tramadol Hcl (1unit Twice Per Day)

Norvir (100mg Twice Per Day)

Creon (25000iu Four Times Per Day)

Motilium

and developed a serious reaction and side effect(s): Intestinal Obstruction, Abdominal Pain, Nausea after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Debridat treatment in male patients, resulting in Intestinal Obstruction side effect. The patient was hospitalized.

This report suggests a potential DebridatToxic Skin Eruption side effect(s) that can have serious consequences. A 58-year-old female patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Debridat (dosage: 600 Mg, 1x/day) starting

This Cardiac Disorder problem was reported by a consumer or non-health professional from Mexico. A 84-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On

Jun 01, 2009 this consumer started treatment with Debridat (dosage: Unk). The following drugs were being taken at the same time:

Diovan Hct (1 Tablet (160/12.5mg) Daily)

Clonazepam

Diovan Hct (1 Tablet (80/12.5 Mg) Daily)

When using Debridat, the patient experienced the following unwanted symptoms/side effects: Cardiac Disorder, Blood Pressure Increased, Headache, Malaise, Palpitations, Blood Pressure DecreasedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cardiac Disorder, may become evident only after a product is in use by the general population.

This Dry Mouth side effect was reported by a physician from France. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Debridat (drug dosage: NA), which was initiated on NS. Concurrently used drugs:

Nexium (20 Mg, Each Evening)

Aldactone (75 Mg, Each Morning)

Aprovel /fra/ (75 Mg, Each Morning)

Anafranil (25 Mg, Each Evening)

Ciflox (Unk, 2/d)

Lyrica (50 Mg, 2/d)

Alprazolam (0.25 Mg, Daily (1/d))

Transipeg /fra/

.After starting to take Debridat the consumer reported adverse symptoms, such as: Dry Mouth, Creatinine Renal Clearance Decreased, Hypotension, HyponatraemiaThese side effects may potentially be related to Debridat. The patient was hospitalized.

This is a report of a 61-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Debridat (dosage: NA, start time:

Jan 17, 2007), combined with:

Smecta

Revlimid

Tiorfan

and developed a serious reaction and side effect(s): Diarrhoea, Abdominal Pain, Weight Decreased, Vomiting after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Debridat treatment in male patients, resulting in Diarrhoea side effect. The patient was hospitalized.

The appearance of Debridat on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

You can use them to remind you of details that may alert your health care professional(s) to a problem

You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

Log Form

You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

Medicine Name and Dosage:

Side Effects

Scale

Date & Time

Other Medicine(s) or Treatment(s)

Scale: 1 = very mild to 10 = very bad

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Debridat reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

Debridat Reviews

Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Viewing and using of this information is subject to accepting Terms Of Use. PatientsVille.com
does not provide medical advice, diagnosis or treatment. The information regarding adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be
used to estimate the incidence of side effects, adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!